- Investing Ideas
- /
- Polish Pharmaceuticals & Biotech High Growth Potential Companies
Polish Pharmaceuticals & Biotech High Growth Potential Companies
Results
5
Companies with a Future performance score of at least 3, ordered by Future performance score.
5 companies
Captor Therapeutics Spolka Akcyjna
Market Cap: zł158.5m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł34.00
7D
-7.9%
1Y
-55.1%
Mabion
Market Cap: zł151.6m
A biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland.
MAB
zł9.38
7D
-6.8%
1Y
-43.7%
Poltreg
Market Cap: zł157.6m
A biotechnology company, develops therapies for autoimmune diseases.
PTG
zł33.80
7D
-5.6%
1Y
-29.6%
Selvita
Market Cap: zł569.0m
Operates as a contract research organization worldwide.
SLV
zł31.00
7D
-0.6%
1Y
-53.2%
Celon Pharma
Market Cap: zł1.2b
An integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations.
CLN
zł22.00
7D
-1.8%
1Y
41.2%